BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 120, Issue 12, Pages 4569-4582
Publisher
American Society for Clinical Investigation
Online
2010-11-01
DOI
10.1172/jci42869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL
- (2009) W. Ci et al. BLOOD
- Systematic in vivo structure-function analysis of p300 in hematopoiesis
- (2009) E. A. Kimbrel et al. BLOOD
- Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8
- (2009) Michael R. Garbati et al. CANCER LETTERS
- HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling
- (2009) Vikram D. Kekatpure et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6–dependent B cell lymphomas
- (2009) Leandro C Cerchietti et al. NATURE MEDICINE
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma
- (2008) M. Crump et al. ANNALS OF ONCOLOGY
- A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
- (2008) L. C. Cerchietti et al. BLOOD
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
- (2008) K. H. Young et al. BLOOD
- The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas
- (2008) Jeremy S. Abramson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Role of Acetylation and Extracellular Location of Heat Shock Protein 90 in Tumor Cell Invasion
- (2008) Y. Yang et al. CANCER RESEARCH
- Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas
- (2008) L. C. Cerchietti et al. CANCER RESEARCH
- B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma
- (2008) Weimin Ci et al. CURRENT OPINION IN HEMATOLOGY
- Targeting Hsp90: small-molecule inhibitors and their clinical development
- (2008) Tony Taldone et al. CURRENT OPINION IN PHARMACOLOGY
- Current treatment approaches for diffuse large B-cell lymphoma
- (2008) Tim Illidge et al. LEUKEMIA & LYMPHOMA
- The structural basis of protein acetylation by the p300/CBP transcriptional coactivator
- (2008) Xin Liu et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now